Connect with us

Health

Researchers develop broad-spectrum SARS-CoV-2 RBD-based vaccine – News-Medical.Net

In a recent bioRxiv* preprint, the large team of researchers evaluated a SARS-CoV-2 Spike receptor-binding domain ferritin nanoparticle protein vaccine (RFN) in…

Published

on

Article feature image

Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen. Three emergent SARS-like diseases caused by zoonotic betacoronaviruses have caused serious outbreaks in the last two decades. Even as vaccines are administered globally to minimize the infection and severity of the disease, the emergence of circulating variants of concern (VOC) has raised concerns for sustained vaccine efficacy.
The receptor-binding domain (RBD) of the virus’s…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending